iBio

$1.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.68%) Today
-$0.03 (-2.05%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell iBio and other stocks, options, and ETFs commission-free!

About IBIO

iBio, Inc., also called iBio, is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the iBio, Inc. and iBio CDMO business segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX. The listed name for IBIO is iBio, Inc.

CEO
Thomas F. Isett
Employees
4
Headquarters
New York, New York
Founded
1993
Market Cap
265.88M
Price-Earnings Ratio
Dividend Yield
Average Volume
11.81M
High Today
$1.48
Low Today
$1.40
Open Price
$1.42
Volume
8.79M
52 Week High
$7.45
52 Week Low
$0.106

Collections

You May Also Like